Loading insider details...
Latest Form 4 (Mar 4, 2026): Grant/Award of 50,000 CATX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 4, 2026 | Perspective Therapeutics, Inc. (CATX) | Grant/Award | 50,000 | n/a |
| Jan 6, 2026 | Cue Biopharma, Inc. (CUE) | Grant/Award | 24,400 | n/a |
| Mar 5, 2025 | Perspective Therapeutics, Inc. (CATX) | Grant/Award | 50,000 | n/a |
| Jan 3, 2025 | Cue Biopharma, Inc. (CUE) | Grant/Award | 24,400 | n/a |
| Jun 24, 2024 | Perspective Therapeutics, Inc. (CATX) | Grant/Award | 23,000 | n/a |
| Jan 4, 2024 | Cue Biopharma, Inc. (CUE) | Grant/Award | 24,400 | n/a |
| Dec 14, 2023 | Perspective Therapeutics, Inc. (CATX) | Grant/Award | 230,000 | n/a |
| Feb 24, 2023 | Perspective Therapeutics, Inc. (ISR) | Grant/Award | 470,000 | n/a |
| Jan 5, 2023 | Cue Biopharma, Inc. (CUE) | Grant/Award | 10,000 | n/a |
| May 31, 2022 | Cue Biopharma, Inc. (CUE) | Purchase | 28,000 | $105.0K |